Federal regulators responsible for the safety of the U.S. drug supply are still struggling to get back to where they were in 2019, before the COVID-19 pandemic upended factory inspections in the U.S. and across the world, The Associated Press has found.
Nearly 2,000 drug manufacturing plants overdue for FDA inspections after COVID delays, AP finds
Related Posts
EU threatens Apple with fines if it doesn’t open up highly guarded iOS software to rivals
EU antitrust regulators on Thursday warned Apple to throw open its fiercely-guarded proprietary software to rivals — or risk the prospect of major fines from. The European Commission launched so-called specification…
European Union moves to compel Apple to open up operating system to rival tech
The European Union says it will outline steps to compel Apple to open up its iPhone and iPad operating systems to competing technologies under the bloc’s tough new digital rulebook,…